{"entity":{"id":"pcdc","kind":"drug","name":"PCDC","aka":[],"tldr":"PCDC is an experimental humanized antibody for an antibody-drug conjugate from Chiome Bioscience, in preclinical development for solid tumours, lung cancer and colorectal cancer and other cancers.","summary":"PCDC is a humanized antibody for an antibody-drug conjugate from Chiome Bioscience. A humanized anti-CDCP1 antibody intended for use in an antibody-drug conjugate. Its furthest stage is preclinical development, for solid tumours, lung cancer, colorectal cancer and pancreatic cancer. No clinical trial naming it is registered on ClinicalTrials.gov. Listed as 'Licensing opportunity' on the pipeline page. It has not been shown to work in people.","status":"preclinical","asOf":"2026-11-03","links":[{"label":"Chiome Bioscience: chiome.co.jp","url":"https://www.chiome.co.jp/en/pipeline/"}],"tags":["pipeline"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["chiome-bioscience"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo gap audit, class 5 (company pipeline pages and ClinicalTrials.gov v2)","editedOn":"2026-11-03"},"code":"PCDC","modality":"Humanized antibody for an antibody-drug conjugate","mechanism":"A humanized anti-CDCP1 antibody intended for use in an antibody-drug conjugate.","approvals":[],"mechanismSteps":[],"toxicity":[],"access":[],"regulatoryEvents":[]},"route":"/drugs/pcdc/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"chiome-bioscience","kind":"company","name":"Chiome Bioscience","route":"/companies/chiome-bioscience/"}]}}